Sugar intake-ability enhancer
CA 2524175 C · Owner: Takagi, Toshiyuki · Inventors: Takagi, Toshiyuki; Shimomura, Iichiro
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a pharmaceutical composition for enhancement of glucose uptake into warm-blooded animal cells, treatment of diabetes treatment or , prevention of diabetes complications etc. treatment or prevention of diabetes or diabetes complications caused by insulin resistance syndrome, and the like comprising as an , active ingredient an HMG-CoA reductase inhibitor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 27, 2004 and granted June 14, 2016. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 27, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 27, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.